We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TDF:NYSETempleton Dragon Fund, Inc. Analysis

Data as of 2026-09-01 - not real-time

$10.79

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Templeton Dragon Fund, Inc. is neutral at $10.79, with no clear ordering between short and long averages. Momentum indicators put RSI at 45.7 (neutral) with MACD reading bearish. Recent trading has carved out support near $10.63 and resistance around $11.26.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 12.1%, a beta of 0.76 and a maximum drawdown of 14.8%, the drawdown profile is forgiving relative to most of the market. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 3/10 conviction on the long call.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Trading below the 200-day average of 11.15
  • MACD momentum is negative
  • Thin trading liquidity raises execution risk

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 11.15
  • MACD momentum is negative
  • Thin trading liquidity raises execution risk

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Thin trading liquidity raises execution risk
  • 30-day volatility of 12.1%
  • Beta of 0.76 versus the benchmark

Key Metrics & Analysis

Closed-End Fund Metrics

Market Price10.785
Discount/Premium0.00%
Discount TrendStable

Technical Analysis

TrendNeutral
RSI45.7
Support$10.63
Resistance$11.26
MA 20$10.90
MA 50$10.80
MA 200$11.15
MACDBearish
VolumeDecreasing
Fear & Greed Index92.57

Risk Assessment

Beta0.76
Volatility12.06%
Sector RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.